BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Boston Scientific Corporation 

One Boston Scientific Place

Natick  Massachusetts  01760  U.S.A.
Phone: 508-650-8000 Fax: 508-647-2393


SEARCH JOBS

View Clinical Trials from BioPharm Insight



 Key Statistics


Email:
Ownership: Public

Web Site: Boston Scientific Corporation
Employees:
Symbol: BSX
 









 Company News
DAPT Funk: Study Raises Questions About Boston Scientific Corporation (BSX)'s Synergy Stent 11/26/2014 7:56:42 AM
Boston Scientific Corporation (BSX) Slammed With $18.5M Verdict In Mesh Trial 11/21/2014 10:28:02 AM
Johnson & Johnson (JNJ) Demands $7.2 Billion From Boston Scientific Corporation (BSX) As Trial Begins 11/21/2014 5:48:24 AM
Boston Scientific Corporation (BSX) Earns Top Marks In Corporate Equality Index 11/19/2014 4:30:05 PM
Boston Scientific Corporation (BSX) Release: New Data From Evolve Clinical Program Demonstrate SYNERGY Bioabsobable Polymer Stent Meets Key Performance Endpoints 11/19/2014 11:49:37 AM
Johnson & Johnson (JNJ) Wants $5 Billion From Boston Scientific Corporation (BSX) For Guidant Corporation (GDT) Jilting 11/19/2014 8:07:10 AM
Boston Scientific Corporation (BSX) Release: First U.S. Procedures Completed With The Symphion™ Hysteroscopic Tissue Removal System 11/17/2014 12:17:39 PM
Boston Scientific Corporation (BSX) Release: Subcutaneous Implantable Defibrillator Receives Favorable Coding And Payment Designations For 2015 11/14/2014 7:55:40 AM
Boston Scientific Corporation (BSX) Ordered To Pay $26.7 Million Over Mesh Devices 11/14/2014 7:09:17 AM
Boston Scientific Corporation (BSX) To Participate In 2014 Stifel Healthcare Conference 11/5/2014 9:09:21 AM
12345678910...